Get started
BridgeBio Pharma, Inc. 2.25% 01-FEB-2029BridgeBio Pharma, Inc. 2.25% 01-FEB-2029BridgeBio Pharma, Inc. 2.25% 01-FEB-2029

BridgeBio Pharma, Inc. 2.25% 01-FEB-2029

No trades
See on Supercharts
Overview
Analysis News

BBIO5355568 chart


Full chart

Key terms


Outstanding amount
‪747.50 M‬ USD
Face value
1,000.00 USD
Minimum denomination
1,000.00 USD
Coupon
2.25% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
5.87%
Maturity date
Feb 1, 2029
Term to maturity
3 years

About BridgeBio Pharma, Inc. 2.25% 01-FEB-2029


Issuer
BridgeBio Pharma, Inc.
Sector
Health Technology
Industry
Biotechnology
Home page
bridgebio.com
Issue date
Feb 2, 2022
FIGI
BBG00Z1G6G03
BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

BBIO5355568 analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

BBIO5355568 news



Dive into corporate with bonds that match in maturity and industry.